Russian Clinical Research Market: Problems and Prospects
https://doi.org/10.31432/1994-2443-2022-17-4-65-77
Abstract
The global market for clinical trials is directed at harmonizing international cooperation to address issues of universal provision of high quality and availability of medicines. Considering the ubiquitous nature of digitalization, at the present stage there are a number of barriers that impede the close international cooperation of social agents in the clinical research industry: the fragmentation of the rules and requirements of ethical and legal regulation, as well as significant disadvantages in the popularization of such research in the public mind. The Russian clinical trials sector is lagging behind in the development of digital volunteer/patient search services, that reduces the ability to conduct large valid clinical trials with human participation. The article presents data from a comparative analysis of popular digital volunteer/patient search services currently available on the global Internet for their compliance with the requirements of a consumer request, and also suggests options for their improvement. The result of the study was the identification of problem areas of the modern market for international clinical trials, as well as factors lagging behind the Russian sector due to the imbalance of the legislative framework and the low quality of domestic digital platforms for promoting and attracting volunteers
About the Authors
I. I. Tsarikov
Sechenov First Moscow State Medical Univesity
Russian Federation
Russian Federation
bachelor student of the Institute of Linguistics and Intercultural Communication
8-2, Trubetskaya street, Moscow, 119992
S. V. Miheenko
Sechenov First Moscow State Medical Univesity
Russian Federation
Russian Federation
bachelor student of the Institute of Linguistics and Intercultural Communication
8-2, Trubetskaya street, Moscow, 119992
References
1. Sajt GKB im. A.K. Eramishanceva [Elektronnyj resurs] Klinicheskie issledovaniya — GKB imeni A.K. Eramishanceva (URL: gkbe.ru) (date of the application 11.11.2022).
2. Upravlenie klinicheskimi issledovaniyami / pod obshch. red. Belousova D. YU., Zyryanova S. K., Kolbina A. S. — 1-e izd. — M.: Buki Vedi: Izdatel’stvo OKI, 2017. — [1, с. 676],
3. «Klinicheskie issledovaniya. metodologiya razrabotki i principy provedeniya» / pod obshch. red. A.N. Vasil’eva, R.R. Niyazova, E.YU. Parfenovoj, T.V. Eremenkovoj, A.P. Solov’evoj, V.K. Adonina – Vedomosti NCESMP №4, 2012.
4. Cochrane AL. Eff ectiveness and efficiency: random reflection on health services. — London: Nuffield Provincial Hospitals Trust. 1972. [cited 2020 Jul 25]. Available from: URL: https://www.nuffieldtrust.org.uk/files/2017-01/effectivenessand-efficiency-web-final.pdf DOI: 10.1016/S0033-3506(73)80082-4.
5. YAvelov I.S. Randomizirovannye klinicheskie issledovaniya i analiz povsednevnoj klinicheskoj praktiki: chto eto znachit dlya klinicista. Lekciya // Aterotromboz. 2018. [1, c. 43-51].
6. SHevchenko O.R., Kolbin A.S. Pragmaticheskie klinicheskie issledovaniya // Kachestvennaya klinicheskaya praktika. 2020. [3, с 52-60].
7. Beschastnova S.P. Sovremennye trendy investicionnoj aktivnosti i kommunikacij na farmacevicheskom rynke v usloviyah tekushchih peremen // Innovacii i investicionnoj [9, с. 19-25].
8. Sajt Konsul’tantPlyus [Elektronnyj resurs] Federal’nyj zakon “Ob obrashchenii lekarstvennyh sredstv” ot 12.04.2010 N 61- FZ (poslednyaya redakciya) \ Konsul’tant-Plyus (URL: consultant.ru) (date of the application 10.11.2022).
9. Sikachyov V.V., Gorin V.V., Kolbin A.S., Belousov D.YU. Pravovye aspekty provedeniya issledovanij real’noj klinicheskoj praktiki // Kachestvennaya klinicheskaya praktika. 2020. [5, с. 64-69].
10. Goryacheva T.S. Zakonodatel’noe regulirovanie mediko-biologicheskih issledovanij s uchastiem cheloveka: istoriko-pravovoj aspekt // Pravovaya politika i pravovaya zhizn’. 2022. [1, с. 132- 140.]
11. Ross S, Grant A, Counsell CE, et al. Barriers to participation in randomised controlled trials: a systematic review. JClinEpidemiol. 1999;52(12):1143-1156. DOI: 10.1016/S0895-4356(99)00141-9.
12. rivenko S.I. Normativno – pravovoe regulirovanie biomedicinskih kletochnyh produktov // Medicinskie novosti. 2020. [8 (311), с. 18-20].
13. Issledovaniya real’noj klinicheskoj praktiki / A.S. Kolbin, D.YU. Belousov, S.K. Zyryanov i dr. — M.: Izdatel’stvo OKI: Buki Vedi; 2020. — 208 s.: il. ISBN 978-5-4465-2902-5.
14. Alemayehu C, Mitchell G, Nikles J. Barriers for conducting clinical trials in developing countries — a systematic review. International Journal for Equity in Health. 2018;17(1). DOI: 10.1186/s12939-018-0748-6.
15. AparcinK.A. «Azart» issledovatelya. Organizacionnye aspekty provedeniya klinicheskih issledovanij. — M.: Remedium; 2017. — c. 48–49.
16. Sajt URL: ClinLine [Elektronnyj resurs] ClinLine – platforma po poisku klinicheskih issledovanij i vzaimodejstviyu pacientov, zdorovyh dobrovol’cev i issledovatelej. (date of the application 11.11.2022).
17. Sajt URL: Antidote.me [Elektronnyjresurs] ClinicalTrialPatientRecruitment | Antidote (date of the application 11.11.2022).
18. Sajt Associacii organizacij po klinicheskim issledovaniyam. [Elektronnyj resurs] URL: http://acto-russia.org/. (date of the application 11.11.2022).
Review
For citations:
Tsarikov I.I., Miheenko S.V. Russian Clinical Research Market: Problems and Prospects. Information and Innovations. 2022;17(4):65-77. (In Russ.) https://doi.org/10.31432/1994-2443-2022-17-4-65-77
Views:
529
Email this article 